| News & Announcements | Expiration of Coverage for Consumer Grade Pulse Oximeters Effective January 1, 2022 for Commercial Members | | | | | | 12/2/2021 | | | |
| News & Announcements | Coverage of Speech Therapy Services Performed Through Telemedicine for Independence Commercial Members (Updated January 1, 2022) | | | | | | 12/31/2021 | | | |
| News & Announcements | Pharmaceutical Treatments of COVID-19 for Independence Commercial Members (Effective January 1, 2022) | | | | | | 12/31/2021 | | | |
| News & Announcements | Coverage of the COVID-19 Vaccination for Independence Commercial Members (Effective January 1, 2022) | | | | | | 12/31/2021 | | | |
| News & Announcements | ADUHELM™ (aducanumab-avwa) injection for Commercial Members (Updated January 1, 2022) | | | | | | 12/31/2021 | | | |
| News & Announcements | 1/01/2022 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products | | | | | | 12/31/2021 | | | |
| Notifications | eviCore Lab Management (Independence) | 06.02.52w | 12/1/2021 9:00 AM | 1/1/2022 | | | 12/1/2021 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Notifications | Breast Pumps | 05.00.76e | 12/17/2021 10:00 AM | 1/17/2022 | | | 12/17/2021 | Medical Necessity Criteria | | |
| Notifications | Electromyography (EMG) Studies: Needle EMG, Surface EMG (SEMG) | 07.03.09s | 12/20/2021 12:00 PM | 3/21/2022 | | | 12/20/2021 | Coverage and/or Reimbursement Position;Medical Necessity Criteria | | |
| Notifications | Nerve Conduction Studies (NCS) and Related Electrodiagnostic Studies | 07.03.18r | 12/20/2021 12:00 PM | 3/21/2022 | | | 12/20/2021 | Coverage and/or Reimbursement Position;Medical Necessity Criteria | | |
| Notifications | Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (Phesgo®) | 08.01.72a | 12/21/2021 7:00 AM | 3/21/2022 | | | 12/21/2021 | Medical Necessity Criteria | | |
| Notifications | pegfilgrastim (Neulasta®) and related biosimilars | 08.01.32h | 12/31/2021 9:00 AM | 4/1/2022 | | | 12/31/2021 | Coverage and/or Reimbursement Position | | |
| Notifications | Rituximab (Rituxan®) Infusion and Related Biosimilars, and Rituximab/Hyaluronidase Human for Subcutaneous Injection (Rituxan Hycela®) | 08.00.50z | 12/31/2021 9:00 AM | 4/1/2022 | | | 12/31/2021 | Coverage and/or Reimbursement Position | | |
| New Policies | Tisotumab vedotin-tftv (Tivdak™) | 08.01.83 | | 12/20/2021 | | | 12/20/2021 | This is a New Policy. | | |
| New Policies | Pain Management of Peripheral Nerves by Injection | 07.03.27 | 9/27/2021 12:00 PM | 12/27/2021 | | | 12/27/2021 | This is a New Policy. | | |
| Updated Policies | Modifier 53: Discontinued Procedure | 03.00.33b | | 12/6/2021 | | | 12/5/2021 | General Description, Guidelines, or Informational Update | | |
| Updated Policies | Sacituzumab govitecan-hziy (TrodelvyTM) | 08.01.60c | | 12/6/2021 | | | 12/6/2021 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Carfilzomib (Kyprolis®) | 08.01.05h | | 12/6/2021 | | | 12/6/2021 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Ado-Trastuzumab Emtansine (Kadcyla®) | 08.01.11g | | 12/6/2021 | | | 12/6/2021 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Hospice Care | 02.02.01h | | 12/6/2021 | | | 12/6/2021 | General Description, Guidelines, or Informational Update | | |
| Updated Policies | Modifier 52: Reduced Services | 03.00.32b | | 12/6/2021 | | | 12/6/2021 | General Description, Guidelines, or Informational Update | | |
| Updated Policies | Evaluation and Management of Autism Spectrum Disorder (ASD) | 07.03.07w | | 12/6/2021 | 12/6/2021 | | 12/6/2021 | Coverage and/or Reimbursement Position | | |
| Updated Policies | Outpatient Physical Medicine, Rehabilitation, and Habilitation Services | 10.03.01m | | 12/20/2021 | 12/20/2021 | | 12/20/2021 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Nutritional Formulas, Enteral Nutrition, Medical Foods, Low-Protein Modified Food Products, and Donated Breast Milk | 08.00.18o | 11/19/2021 8:00 AM | 12/20/2021 | | | 12/20/2021 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)/(Abraxane® for Injectable Suspension) | 08.00.90m | | 12/20/2021 | | | 12/20/2021 | Medical Necessity Criteria | | |
| Updated Policies | Pertuzumab (Perjeta®) | 08.01.07h | | 12/20/2021 | | | 12/20/2021 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Wound Care: Skin Substitutes for the Treatment of Burns and Chronic, Non-Healing Wounds | 11.08.20z | | 12/20/2021 | | | 12/20/2021 | General Description, Guidelines, or Informational Update | | |
| Updated Policies | Infliximab and Related Biosimilars | 08.00.34p | | 12/20/2021 | | | 12/20/2021 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Personalized Vaccines (e.g. Provenge®) | 08.00.95f | | 12/20/2021 | | | 12/20/2021 | Medical Necessity Criteria | | |
| Updated Policies | Enfortumab vedotin-ejfv (Padcev®) | 08.00.43c | | 12/20/2021 | | | 12/20/2021 | Medical Necessity Criteria | | |
| Updated Policies | eviCore Lab Management (Independence) | 06.02.52w | 12/1/2021 9:00 AM | 1/1/2022 | | | 12/31/2021 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Preventive Care Services | 00.06.02ah | 10/1/2021 9:00 PM | 1/1/2022 | | | 12/31/2021 | Medical Necessity Criteria;Medical Coding | 12/31/2021 | |
| Updated Policies | Dermabrasion for Rhinophyma, Septoplasty, Rhinoplasty, and Septorhinoplasty | 11.16.01i | | 1/3/2022 | | | 12/31/2021 | Coverage and/or Reimbursement Position;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Intraoperative Neurophysiological Monitoring (INM) | 07.03.14q | | 1/3/2022 | | | 12/31/2021 | Coverage and/or Reimbursement Position;General Description, Guidelines, or Informational Update | | |
| Updated Policies | National Correct Coding Initiative (NCCI) Code Pair Edits | 00.01.56b | | 1/3/2022 | | | 12/31/2021 | Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Reporting and Documentation Requirements for Anesthesia Services | 00.01.14s | | 1/1/2022 | | | 12/31/2021 | Coverage and/or Reimbursement Position;Medical Coding | | |
| Reissue Policies | Cobalamin (Vitamin B12), Folic Acid, and Homocysteine Testing | 06.02.54b | | 10/1/2021 | 11/17/2021 | | 12/15/2021 | | | |
| Reissue Policies | Colorectal Cancer Screening | 11.03.12t | | 7/1/2021 | 11/17/2021 | | 12/15/2021 | | | |
| Reissue Policies | Patisiran (Onpattro™) | 08.01.50b | | 10/1/2019 | 11/17/2021 | | 12/15/2021 | | | |
| Reissue Policies | Esophagogastroduodenoscopy (EGD) and Endoscopic Retrograde Cholangiopancreatography (ERCP) | 07.02.22b | | 10/1/2020 | 11/17/2021 | | 12/15/2021 | | | |
| Reissue Policies | Therapies for Spinal Muscular Atrophy Nusinersen (Spinraza®) and Onasemnogene abeparvovec-xioi (Zolgensma®) | 08.01.36e | | 7/1/2020 | 11/17/2021 | | 12/15/2021 | | | |
| Reissue Policies | Measurement of Exhaled Nitric Oxide and Breath Condensate in the Diagnosis and Management of Asthma and Other Respiratory Disorders | 07.11.02f | | 3/26/2018 | 11/17/2021 | | 12/15/2021 | | | |
| Coding Update | Pulmonary Rehabilitation | 10.04.01m | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Spinal Laminectomy (Independence Administrators) | 11.14.28e | | 1/1/2022 | 1/1/2022 | | 12/31/2021 | | | |
| Coding Update | Spinal Fusion (Independence Administrators) | 11.14.27f | | 1/1/2022 | 1/8/2022 | | 12/31/2021 | | | |
| Coding Update | Musculoskeletal Services (Independence) | 00.01.66e | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Ambulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) Monitoring | 07.02.21h | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Endovascular Stent-Graft Repair of Thoracic Aortic Aneurysms and Nonaneurysmal Lesions | 11.02.17g | | 1/1/2022 | 1/1/2022 | | 12/31/2021 | | | |
| Coding Update | Bone Mineral Density (BMD) Testing | 09.00.04l | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Wireless Capsule Endoscopy (WCE) as a Diagnostic Technique in Disorders of the Small Bowel, Esophagus, and Colon | 07.05.02o | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | High-Technology Radiology Services | 09.00.46ai | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | pegfilgrastim (Neulasta®) and related biosimilars | 08.01.32f | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Genetic Testing (Independence Administrators) | 06.02.35ae | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Assays of Genetic Expression in Tumor Tissue for Breast Cancer Prognosis (Independence Administrators) | 06.02.27m | | 12/31/2021 | | | 12/31/2021 | | | |
| Coding Update | Chimeric Antigen Receptor (CAR) Therapy | 08.01.43j | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Orthoptic/Pleoptic Training | 07.13.01i | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Autonomic Nervous System Testing | 07.03.23e | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Cataract Surgery | 11.01.07f | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Stem-Cell Therapy for Orthopedic Applications and Autologous Platelet-Derived Growth Factors (PDGFs)/Platelet-Rich Plasmas (PRPs) for Acute or Chronic Wound Healing and Other Miscellaneous Conditions | 07.07.09h | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Catheter Ablation of Cardiac Arrhythmias | 11.02.06n | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Endovascular Grafts for Abdominal Aortic Aneurysms (AAA), Aortic-Iliac Aneurysms, and Infrarenal Aortic Aneurysms | 11.02.10p | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions | 11.14.13h | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Telemedicine Services | 00.10.41i | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Vagus Nerve Stimulation (VNS) | 11.15.16q | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Aqueous Shunts, Microstents, Viscocanalostomy, and Canaloplasty for the Treatment of Glaucoma | 11.05.16j | | 1/1/2022 | | | 12/31/2021 | | | |
| Coding Update | Noninvasive Techniques for the Evaluation and Monitoring of Individuals with Chronic Liver Disease | 06.02.56e | | 1/1/2022 | | | 12/31/2021 | | | |
| Archived Policies | Melphalan flufenamide (Pepaxto®) | 08.01.78b | 12/1/2021 3:00 PM | 1/1/2022 | | | 12/1/2021 | | | |
| Archived Policies | Ibalizumab-uiyk (Trogarzo™) | 08.01.46a | 12/3/2021 1:00 PM | 1/3/2022 | | | 12/3/2021 | | | |
| Archived Policies | Tagraxofusp-erzs (Elzonris®) | 08.01.55c | 12/3/2021 2:00 PM | 1/3/2022 | | | 12/3/2021 | | | |